Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Industry sponsor intelligence

Beijing Northland Biotech. Co., Ltd.Clinical Pipeline.

Lead-sponsor view of Beijing Northland Biotech. Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total
5
Recruiting
0
Active
1
Completed
4
Results posted
0
Avg enrollment
85

Pipeline overview

Programs by phase and activity.

Velocity

Beijing Northland Biotech. Co., Ltd. trials by start year

Study start year · indexed snapshot

1110020172017: 1 trials2018: 1 trials20192019: 0 trials2020: 1 trials20212021: 0 trials2022: 1 trials20232023: 0 trials2024: 0 trials20252025: 0 trials20262026: 1 trials

Development

Trials by phase

Early Phase 10
Phase 12
Phase 23
Phase 30
Phase 40
ProductStudiesEarly / IPhase IIPhase IIIPhase IVActive
Thymosin Beta-4 →523001

Active peptide trials

In motion now.

Completed trials

Finished registry records.

Search sponsor records

All Beijing Northland Biotech. Co., Ltd. studies.

This page groups studies where Beijing Northland Biotech. Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.

5 matching studies

End of 5 results

Recent updates

Latest registry movement.

NCT07586865Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial InfarctionMay 14, 2026NCT05984134Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial InfarctionJun 21, 2024NCT05485818Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.InfarctionAug 3, 2022NCT04555824A Phase 1a Study of Thymosin Beta 4 in Healthy VolunteersSep 29, 2020NCT04555850A Phase 1b Study of Thymosin Beta 4 in Healthy VolunteersSep 29, 2020